Research Paper Volume 16, Issue 7 pp 5866—5886
NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression
Figure 7. NXPH4 and drug sensitivity in colon cancer. (A) Relationship between NXPH4 and TMB in colon cancer. (B) Relationship between NXPH4 and MSI in colon cancer. (C) Difference of TIDE score between high and low NXPH4 expression groups in colon cancer. (D) GSCA online tool was used to analyze the correlation between NXPH4 expression and chemotherapeutic drug IC50 in GDSC database. (E) GSCA online tool to analyze the correlation between NXPH4 expression and chemotherapy drug IC50 in CTRP database.